Company Badge
USPTO Data Jan 1 1976 - Dec 30 2025
9 Patents
#473 in San Francisco, CA
#7,510 in California
#31,660 in US
Blackthorn Therapeutics, Inc.
Forward Citations = 17
23 inventors:
San Francisco, CA, United States of America
Blackthorn Therapeutics, Inc.
EPO Patents = 2
Trademarks = 1
Forward Citations = 17
Loading Chart...
Loading Chart...
23 inventors (with patents filed for the assignee):
Robert M Jones (5 out of 85 patents)
Mariangela Urbano (5 out of 11 patents)
Parvez Ahammad (3 out of 16 patents)
4. Monika Sharma Mellem (3 out of 7 patents)
5. Yuelu Liu (3 out of 9 patents)
6. Humberto Andres Gonzalez Cabezas (3 out of 9 patents)
7. Edward Roberts (3 out of 17 patents)
8. Miguel A Guerrero (3 out of 14 patents)
9. Hugh Rosen (3 out of 16 patents)
10. Candace Mae Laxamana (3 out of 3 patents)
11. Xianrui Zhao (3 out of 3 patents)
12. Eric Douglas Turtle (3 out of 28 patents)
13. David Hardick (2 out of 6 patents)
14. Chris Knight (2 out of 14 patents)
15. Jason Tierney (2 out of 5 patents)
9 patents:
1. 11897873 - Kappa opioid receptor antagonists and products and methods related thereto (2024-02-13),
4. 11186577 - Vasopressin receptor antagonists and products and methods related thereto (2021-11-30),
6. 11124504 - Kappa opioid receptor antagonists and products and methods related thereto (2021-09-21),
Blackthorn Therapeutics is a clinical stage biopharmaceutical company pioneering the next generation of brain-directed therapeutics in neuroscience. The company leverages a deep understanding of neurobiology to develop targeted treatments for neurobehavioral disorders. Blackthorn's goal is to address the significant unmet medical needs in areas such as mood disorders, schizophrenia, and autism spectrum disorder.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Please report any incorrect information to support@idiyas.com
2 patents (EPO):
Please report any incorrect information to support@idiyas.com